Fosamax As Cancer Treatment Reported To Have Increased Risk For Osteonecrosis Of The Jaw (onj)
An increasing number of reports claiming the drug Fosamax, a bisphosphonate drug going by the generic name of Alendronate Sodium, have the uncanny disposition to incur grave adverse effect to Fosamax users such as osteonecrosis of the jaw. The disease condition occurs because there is an unusual change in the amount of blood supply to the affected part causing it to decrease. Recently published article from The Journal of Rheumatology contain reports of the study conducted regarding Fosamax's tendency to cause osteonecrosis of the jaw to its users.
There were 32 cases of ONJ occurrences between 2004 and 2006 experienced by patients taking the infamous drug, as reported by the researchers digging into the files. Bisphosphonate drug was used by the involved 32 patients during the time they had ONJ. The report also showed that most of the affected cases took the said drug intravenously while 13 of them by mouth. It was found that there is a significant difference in the strength of the drug's effect to a person, such as with the cancer patients involved a few years ago, setting intravenous drugs as a mode of administration which provides more potent strength compared to oral administration. Intravenous administration of the bisphosphonate drug amplifies its drug's effect compared to oral administration of the drug. This finding does not lead us to the range of ONJ possibility of Fosamax users.
The battle of the Fosamax Osteonecrosis of the Jaw litigation has been debated inside the U.S. District Court for the Southern District of New York for quite some time now. The motion for consolidation of all ONJ cases into one MDL case is still centered with bellwether cases. Last April, Merck filed a motion for ONJ consolidation which meant the MDL progress for ONJ lawsuits will be later than Fosamax complainants had hoped for.
If you were injured by Fosamax and experienced any of the given Fosamax side effects, such as osteonecrosis of the jaw, you can set your Fosamax lawsuit into action by talking to a reliable and adept Fosamax lawyer. You can set your Fosamax fracture lawsuit into motion after consulting a reliable Fosamax lawyer for free. For more information, visit Fosamax lawsuit sites right now.
There were 32 cases of ONJ occurrences between 2004 and 2006 experienced by patients taking the infamous drug, as reported by the researchers digging into the files. Bisphosphonate drug was used by the involved 32 patients during the time they had ONJ. The report also showed that most of the affected cases took the said drug intravenously while 13 of them by mouth. It was found that there is a significant difference in the strength of the drug's effect to a person, such as with the cancer patients involved a few years ago, setting intravenous drugs as a mode of administration which provides more potent strength compared to oral administration. Intravenous administration of the bisphosphonate drug amplifies its drug's effect compared to oral administration of the drug. This finding does not lead us to the range of ONJ possibility of Fosamax users.
The battle of the Fosamax Osteonecrosis of the Jaw litigation has been debated inside the U.S. District Court for the Southern District of New York for quite some time now. The motion for consolidation of all ONJ cases into one MDL case is still centered with bellwether cases. Last April, Merck filed a motion for ONJ consolidation which meant the MDL progress for ONJ lawsuits will be later than Fosamax complainants had hoped for.
If you were injured by Fosamax and experienced any of the given Fosamax side effects, such as osteonecrosis of the jaw, you can set your Fosamax lawsuit into action by talking to a reliable and adept Fosamax lawyer. You can set your Fosamax fracture lawsuit into motion after consulting a reliable Fosamax lawyer for free. For more information, visit Fosamax lawsuit sites right now.
Source...